GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » EPS (Basic)

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) EPS (Basic) : $-0.00 (TTM As of Jun. 2018)


View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings EPS (Basic)?

CTT Pharmaceutical Holdings's basic earnings per share (Basic EPS) for the three months ended in Jun. 2018 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2018 was $-0.00.

CTT Pharmaceutical Holdings's EPS (Diluted) for the three months ended in Jun. 2018 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2018 was $-0.00.

CTT Pharmaceutical Holdings's EPS without NRI for the three months ended in Jun. 2018 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2018 was -0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


CTT Pharmaceutical Holdings EPS (Basic) Historical Data

The historical data trend for CTT Pharmaceutical Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTT Pharmaceutical Holdings EPS (Basic) Chart

CTT Pharmaceutical Holdings Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.20 -1.10 -0.01 0.01 -0.07

CTT Pharmaceutical Holdings Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Mar17 Jun17 Mar18 Jun18
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - -0.01 - -

CTT Pharmaceutical Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

CTT Pharmaceutical Holdings's Basic EPS for the fiscal year that ended in Dec. 2015 is calculated as

Basic EPS (A: Dec. 2015 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.446-0)/20.867
=-0.07

CTT Pharmaceutical Holdings's Basic EPS for the quarter that ended in Jun. 2018 is calculated as

Basic EPS (Q: Jun. 2018 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.091-0)/21.3193
=-0.05

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CTT Pharmaceutical Holdings  (OTCPK:CTTH) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


CTT Pharmaceutical Holdings EPS (Basic) Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6
CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.
Executives
Albert C Zapanta director PO BOX 2020, SPRINGDALE AR 72765
William Thomson director 390 BAY ST, SUITE 1102, TORONTO ONTARIO A6 M5H 2Y2

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Headlines